Precipio Signs Another HemeScreen™ Customer
04 5월 2023 - 11:00PM
Specialty cancer diagnostics company Precipio,
Inc. (NASDAQ: PRPO) announces another agreement with a new
customer to bring HemeScreen™ technology into their laboratory.
With each additional customer, Precipio continues to execute on its
strategy, converting pipeline prospects to actual customers, and
progressing towards breakeven.
The company incurs
virtually no additional costs for the onboarding and maintenance of
new customers, except for COGS and associated production costs,
which represent a relatively low cost of goods, generating a
healthy margin for the Company. Because our cost and business
structure for the Products Division is largely fixed, each new
customer has a substantial financial impact and contribution to the
bottom line.
“As promised, we
continue to convert our pipeline of potentials into actual signed
customers, adding to the building blocks of recurring revenue, with
each customer helping to reduce our cash burn, and bringing us
closer to our breakeven goals,” said Ilan Danieli, Precipio’s CEO.
“Shareholders can expect more of these customers joining the ranks
of our HemeScreen family, as we continue to support our customers
in providing better patient care and improved economics through our
proprietary technologies.”
About Precipio
Precipio has built a platform designed to
eradicate the problem of misdiagnosis by harnessing the intellect,
expertise and technology developed within academic institutions and
delivering quality diagnostic information to physicians and their
patients worldwide, as well as proprietary products that serve
laboratories worldwide. Through its collaborations with world-class
academic institutions specializing in cancer research, diagnostics
and treatment, Precipio offers a new standard of diagnostic
accuracy enabling the highest level of patient care. For more
information, please visit www.precipiodx.com.
Please follow us on LinkedIn, Twitter
@PrecipioDx and on Facebook.
Forward-Looking Statements
This press release contains “forward-looking
statements” within the meaning of Section 27A of the Securities Act
of 1933, as amended, and Section 21E of the Securities Exchange Act
of 1934, as amended, including, among others, statements related to
the expected or potential impact of the novel coronavirus
(COVID-19) pandemic, and the related responses of the government,
consumers, and the company, on our business, financial condition
and results of operations, and any such forward-looking statements,
whether concerning the COVID-19 pandemic or otherwise, involve
risks, assumptions and uncertainties. Except for historical
information, statements about future volumes, sales, growth, costs,
cost savings, margins, earnings, earnings per share, diluted
earnings per share, cash flows, plans, objectives, expectations,
growth or profitability are forward-looking statements based on
management’s estimates, beliefs, assumptions and projections. Words
such as “could,” “may,” “expects,” “anticipates,” “will,”
“targets,” “goals,” “projects,” “intends,” “plans,” “believes,”
“seeks,” “estimates,” “predicts,” and variations on such words, and
similar expressions that reflect our current views with respect to
future events and operational, economic and financial performance,
are intended to identify such forward-looking statements. These
forward-looking statements are only predictions, subject to risks
and uncertainties, and actual results could differ materially from
those discussed. Important factors that could affect performance
and cause results to differ materially from management’s
expectations, or could affect the company’s ability to achieve its
strategic goals, include the uncertainties relating to the impact
of COVID-19 on the company’s business, operations and employees and
the other factors that are described in the sections entitled “Risk
Factors” and “Management’s Discussion and Analysis” in the
company's Annual Report on Form 10-K for the fiscal year ended
December 31, 2021, as updated from time to time in the company’s
Securities and Exchange Commission filings.
The company’s forward-looking statements in this
press release are based on management’s current views, beliefs,
assumptions and expectations regarding future events and speak only
as of the date of this release. The company undertakes no
obligation to publicly update or revise any forward-looking
statements, whether as a result of new information, future events
or otherwise, except as required by the federal securities
laws.
Inquiries:
investors@precipiodx.com
+1-203-787-7888 Ext. 523
Precipio (NASDAQ:PRPO)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
Precipio (NASDAQ:PRPO)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024